Results 201 to 210 of about 922,034 (400)
The Doherty Power Amplifier: Review of Recent Solutions and Trends
V. Camarchia +5 more
semanticscholar +1 more source
A Ka-Band CMOS Transmit/Receive Amplifier with Embedded Switch for Time-Division Duplex Applications. [PDF]
Gu P, Zhang J, Zhao D.
europepmc +1 more source
The Water‑Bridge Mycelium Amplifier: A Bio‑Hybrid Module for Topological Signal Transduction
margolin, ido
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Nonlinearity- and Dispersion-Controlled High-Energy All-Fiber Femtosecond Laser System with Peak Power Exceeding 0.5 GW. [PDF]
Li F +10 more
europepmc +1 more source
Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley +1 more source
Design of Dual Continuous-Mode Class-J Power Amplifiers with Harmonic Matching Networks for X and Ku Bands. [PDF]
Yuan Y, Zhao X, Fan J, Yu Z.
europepmc +1 more source
Basroparib inhibits YAP‐driven cancers by stabilizing angiomotin
Basroparib, a selective tankyrase inhibitor, suppresses Wnt signaling and attenuates YAP‐driven oncogenic programs by stabilizing angiomotin. It promotes AMOT–YAP complex formation, enforces cytoplasmic YAP sequestration, inhibits YAP/TEAD transcription, and sensitizes YAP‐active cancers, including KRAS‐mutant colorectal cancer, to MEK inhibition.
Young‐Ju Kwon +4 more
wiley +1 more source

